Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Colorectal Neoplasms

  Free Subscription


1 Am J Surg
1 Ann Oncol
2 Ann Surg Oncol
1 Anticancer Res
4 BMC Cancer
1 BMC Gastroenterol
3 Br J Cancer
2 Cancer
3 Clin Cancer Res
7 Dis Colon Rectum
1 Eur J Surg Oncol
2 Gastroenterology
3 Gastrointest Endosc
8 Int J Cancer
4 Int J Colorectal Dis
1 J Clin Oncol
1 J Surg Oncol
1 Lancet Oncol
1 PLoS One
1 World J Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. EDWARDS A, Monroe R, Amram O, Kumar A, et al
    Distance to endoscopy services amplifies racial inequities in colorectal cancer mortality in Washington state.
    Am J Surg. 2024 Apr 18:S0002-9610(24)00198-3. doi: 10.1016/j.amjsurg.2024.
    PubMed         Abstract available

    Ann Oncol

  2. BRENNER H, Niedermaier T, Hoffmeister M
    Sensitivity of a blood ctDNA-based multimodal test for the detection of advanced colorectal neoplasms.
    Ann Oncol. 2024;35:476-477.

    Ann Surg Oncol

  3. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    Disparities in Colorectal Cancer Screening.
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.

  4. BEKKI T, Shimomura M, Yano T, Akabane S, et al
    Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.

    Anticancer Res

  5. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
    Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Anticancer Res. 2024;44:2177-2183.
    PubMed         Abstract available

    BMC Cancer

  6. CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al
    Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
    BMC Cancer. 2024;24:546.
    PubMed         Abstract available

  7. ALSADHAN N, Alhurishi SA, Pujades-Rodriguez M, Shuweihdi F, et al
    Demographic and clinical characteristics associated with advanced stage colorectal cancer: a registry-based cohort study in Saudi Arabia.
    BMC Cancer. 2024;24:533.
    PubMed         Abstract available

  8. RAO L, Xu P, Zhang G, Zu R, et al
    Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection.
    BMC Cancer. 2024;24:543.
    PubMed         Abstract available

  9. WU Y, Chen C, Hua X, Zhao C, et al
    Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:537.
    PubMed         Abstract available

    BMC Gastroenterol

  10. BREZINA S, Leeb G, Baierl A, Graf E, et al
    Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.
    BMC Gastroenterol. 2024;24:149.
    PubMed         Abstract available

    Br J Cancer

  11. VILLAREAL LB, Falcon DM, Xie L, Xue X, et al
    Hypoxia-inducible factor 3alpha1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis.
    Br J Cancer. 2024 May 1. doi: 10.1038/s41416-024-02699.
    PubMed         Abstract available

  12. QIAO L, Liu Y, Yang Q
    Comment on: "Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial".
    Br J Cancer. 2024;130:1432-1433.

  13. CAI J, Lin K, Luo T, Weng J, et al
    Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial.
    Br J Cancer. 2024;130:1434-1440.
    PubMed         Abstract available


  14. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.

  15. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed         Abstract available

    Clin Cancer Res

  16. PARIKH AR, Chee BH, Tsai J, Rich TA, et al
    Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
    Clin Cancer Res. 2024 May 2. doi: 10.1158/1078-0432.CCR-23-3660.
    PubMed         Abstract available

  17. WU C, Pai RK, Kosiorek H, Banerjee I, et al
    Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.
    Clin Cancer Res. 2024;30:1811-1821.
    PubMed         Abstract available

  18. KHUSHMAN MM, Toboni MD, Xiu J, Manne U, et al
    Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
    Clin Cancer Res. 2024;30:1906-1915.
    PubMed         Abstract available

    Dis Colon Rectum

  19. CUSTERS PA, Beets GL, Bach SP, Blomqvist LK, et al
    An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal Cancer.
    Dis Colon Rectum. 2024;67:782-795.
    PubMed         Abstract available

  20. CHURCH J
    Being a Colorectal Geneticist.
    Dis Colon Rectum. 2024;67:743-747.

  21. HE S, Zhang J, Wang R, Li L, et al
    Long-term Changes in Low Anterior Resection Syndrome in Survivors of Rectal Cancer: Longitudinal Follow-up of a Randomized Controlled Trial.
    Dis Colon Rectum. 2024;67:834-840.
    PubMed         Abstract available

  22. NEPAL P, Zafar MH, Liu LC, Xu Z, et al
    Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and Survival.
    Dis Colon Rectum. 2024;67:773-781.
    PubMed         Abstract available

  23. WALLER JH, van Kessel CS, Solomon MJ, Lee PJ, et al
    Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
    Dis Colon Rectum. 2024;67:796-804.
    PubMed         Abstract available

  24. IWAMOTO M, Makutani Y, Ushijima H, Ogawa R, et al
    Cranial-First Approach in Robot-Assisted Right Hemicolectomy.
    Dis Colon Rectum. 2024;67:e358.

  25. LEE TG, Ahn HM, Shin HR, Choi MJ, et al
    Totally Extraperitoneal Approach for Recurrent Lateral Pelvic Lymph Nodes After Rectal Cancer Surgery.
    Dis Colon Rectum. 2024;67:e360-e361.

    Eur J Surg Oncol

  26. ZHENG Y, Wang J, Sun L
    Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis.
    Eur J Surg Oncol. 2024 Apr 23:108344. doi: 10.1016/j.ejso.2024.108344.


  27. DE KLAVER W, van der Vlugt M, Spaander MCW, Bossuyt PM, et al
    Risk of cancers proximal to the colon in fecal immunochemical test positive screenees in a colorectal cancer screening program.
    Gastroenterology. 2024 Apr 30:S0016-5085(24)00493.
    PubMed         Abstract available

  28. ZHAO S, He Z, Sui X, Zhang S, et al
    Real-world Stool-based mSDC2 Test Improved Detection of Advanced Colorectal Neoplasia for Colorectal Cancer Screening: A Prospective, Multicenter, Community-based Study.
    Gastroenterology. 2024 Apr 24:S0016-5085(24)00484.

    Gastrointest Endosc

  29. PASAM RT, Chandan S, Mohan BP
    Endoscopic techniques to reduce recurrence after EMR of large nonpedunculated colorectal polyps.
    Gastrointest Endosc. 2024;99:863-864.

    Improving colonoscopy quality: growing evidence to support adenomas per colonoscopy as a standard quality indicator.
    Gastrointest Endosc. 2024;99:796-797.

  31. LI L
    The superiority of blue-light imaging and narrow-band imaging over white-light imaging in the detection of proximal colonic lesions.
    Gastrointest Endosc. 2024;99:864-865.

    Int J Cancer

  32. VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al
    Associations between low- and high-fat dairy intake and recurrence risk in people with stage I-III colorectal cancer differ by sex and primary tumour location.
    Int J Cancer. 2024 May 3. doi: 10.1002/ijc.34959.
    PubMed         Abstract available

  33. BECERRA-TOMAS N, Markozannes G, Cariolou M, Balducci K, et al
    Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34905.
    PubMed         Abstract available

  34. MARKOZANNES G, Becerra-Tomas N, Cariolou M, Balducci K, et al
    Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34903.
    PubMed         Abstract available

  35. CHAN DSM, Cariolou M, Markozannes G, Balducci K, et al
    Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34906.
    PubMed         Abstract available

  36. TSILIDIS KK, Markozannes G, Becerra-Tomas N, Cariolou M, et al
    Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34904.
    PubMed         Abstract available

  37. ZHANG Y, Win AK, Makalic E, Buchanan DD, et al
    Associations between pathological features and risk of metachronous colorectal cancer.
    Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34979.
    PubMed         Abstract available

  38. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    PubMed         Abstract available

  39. HAMMARSTROM K, Nunes L, Mathot L, Mezheyeuski A, et al
    Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Int J Cancer. 2024;155:40-53.
    PubMed         Abstract available

    Int J Colorectal Dis

  40. LOFFLER L, Gogenur I, Gogenur M
    Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort study.
    Int J Colorectal Dis. 2024;39:60.
    PubMed         Abstract available

  41. KONG J, Wu MQ, Yan S, Zhao ZF, et al
    Single-incision plus one-port laparoscopy surgery versus conventional multi-port laparoscopy surgery for colorectal cancer: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2024;39:62.
    PubMed         Abstract available

  42. NIKOLIC A, Tranter-Entwistle I, McCombie A, Connor S, et al
    The utility of synoptic operation reports in colorectal surgery: a systematic review.
    Int J Colorectal Dis. 2024;39:63.
    PubMed         Abstract available

  43. HARDT J, Seyfried S, Brodrecht H, Khalil L, et al
    Remote ischemic preconditioning versus sham-control for prevention of anastomotic leakage after resection for rectal cancer (RIPAL trial): a pilot randomized controlled, triple-blinded monocenter trial.
    Int J Colorectal Dis. 2024;39:65.
    PubMed         Abstract available

    J Clin Oncol

  44. Erratum: Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
    J Clin Oncol. 2024 Apr 30:JCO2400763. doi: 10.1200/JCO.24.00763.

    J Surg Oncol

  45. NAKAO E, Honda M, Uesugi N, Osakabe M, et al
    Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27662.
    PubMed         Abstract available

    Lancet Oncol

  46. ERCAN AB, Aronson M, Fernandez NR, Chang Y, et al
    Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Lancet Oncol. 2024;25:668-682.
    PubMed         Abstract available

    PLoS One

  47. MAEKAWA M, Tanaka A, Ogawa M, Roehrl MH, et al
    Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.
    PLoS One. 2024;19:e0302109.
    PubMed         Abstract available

    World J Surg

  48. BEN-YAACOV A, Levine O, Schtrechman G, Adileh M, et al
    Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
    World J Surg. 2024;48:871-878.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.